Jubilant Pharmova Profile
Key Indicators
- Authorised Capital ₹ 143.02 Cr
- Paid Up Capital ₹ 15.93 Cr
- Company Age 46 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 400.00 Cr
- Satisfied Charges ₹ 8,995.57 Cr
- Revenue Growth 343.79%
- Profit Growth -36.46%
- Ebitda 147.53%
- Net Worth 88.37%
- Total Assets 64.44%
About Jubilant Pharmova
Jubilant Pharmova Limited (JPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 21 June 1978 and has a history of 46 years and seven months. Its registered office is in Jyotiba Phule Nagar, Uttar Pradesh, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 530019 and on the National Stock Exchange(NSE) under JUBLPHARMA.
The Corporate was formerly known as Vam Organic Chemicals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 143.02 Cr and a paid-up capital of Rs 15.93 Cr.
The company currently has active open charges totaling ₹400.00 Cr. The company has closed loans amounting to ₹8,995.57 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jubilant Pharmova Limited India are Naresh Kapoor as Company Secretary, Naresh Kapoor as Company Secretary, and Arvind Chokhany as Cfo. Shyam Bhartia, Hari Bhartia, Priyavrat Bhartia, and Eight other members serve as directors at the Company.
Company Details
- Location
Jyotiba Phule Nagar, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24116UP1978PLC004624
- Company No.
004624
- Stock Symbol
BSE : 530019 NSE : JUBLPHARMA
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Jun 1978
- Date of AGM
31 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Kanpur
Industry
What products or services does Jubilant Pharmova Limited offer?
Jubilant Pharmova Limited offers a wide range of products and services, including Organic Compounds, Piperidine, Third Party Manufacturing Consultancy, Contract Manufacturing Services, Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Pharmaceutical Services.
Who are the key members and board of directors at Jubilant Pharmova?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyavrat Bhartia  | Managing Director | 23-May-2017 | Current |
| Arjun Bhartia | Managing Director | 23-May-2017 | Current |
| Naresh Kapoor | Company Secretary | 01-Aug-2022 | Current |
| Arvind Chokhany | CFO | 01-Jun-2023 | Current |
Board Members (9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Mehra | Director | 23-May-2017 | Current |
| Sushil Roongta | Director | 23-May-2017 | Current |
| Shirish Belapure | Director | 12-Apr-2023 | Current |
| Arun Seth | Director | 22-Oct-2018 | Current |
| Shyam Bhartia | Director | 21-Jun-1978 | Current |
| Hari Bhartia | Director | 01-Nov-1983 | Current |
Financial Performance of Jubilant Pharmova.
Jubilant Pharmova Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 343.79% increase. The company also saw a substantial fall in profitability, with a 36.46% decrease in profit. The company's net worth Soared by an impressive increase of 88.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jubilant Pharmova?
In 2022, Jubilant Pharmova had a promoter holding of 50.68% and a public holding of 49.33%. The company had 7 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zuari Industries LimitedSushil Roongta is a mutual person
Usha Breco LimitedArun Seth is a mutual person
_PRIVATE_LIMITED.webp)
Pamp Technologies (India) Private LimitedArun Seth is a mutual person
Jubilant Enpro Private LimitedShyam Bhartia, Hari Bhartia and 2 more are mutual person
Jubilant Bhartia FoundationShyam Bhartia, Hari Bhartia and 1 more are mutual person
Mahajan Imaging Caring Research LlpHarsh Mahajan is a mutual person
Charges (Loans)
₹400.00 Cr
₹8,995.57 Cr
Charges Breakdown by Lending Institutions
- Others : 230.00 Cr
- Axis Bank Limited : 120.00 Cr
- Yes Bank Limited : 50.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2023 | Others | ₹100.00 Cr | Open |
| 23 Mar 2023 | Yes Bank Limited | ₹50.00 Cr | Open |
| 15 Feb 2023 | Others | ₹60.00 Cr | Open |
| 20 Sep 2022 | Others | ₹70.00 Cr | Open |
| 25 Jul 2022 | Axis Bank Limited | ₹120.00 Cr | Open |
How Many Employees Work at Jubilant Pharmova?
Jubilant Pharmova has a workforce of 1055 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jubilant Pharmova, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jubilant Pharmova's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
